RP Bio Inc. (KOSDAQ:314140)
5,950.00
+270.00 (4.75%)
At close: Jul 31, 2026
-0.83% (1Y)
| Market Cap | 51.56B -0.8% |
| Revenue (ttm) | 137.35B +9.5% |
| Net Income | 5.60B +328.6% |
| EPS | 647.79 +328.4% |
| Shares Out | 8.67M |
| PE Ratio | 9.19 |
| Forward PE | n/a |
| Dividend | 50.00 (0.84%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 23,843 |
| Open | 5,680.00 |
| Previous Close | 5,680.00 |
| Day's Range | 5,500.00 - 5,960.00 |
| 52-Week Range | 4,810.00 - 9,130.00 |
| Beta | 0.47 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |